Axiom Investment Management LLC
Position in GDTC — CytoMed Therapeutics Ltd
CIK 1513703
NEW YORK, NY
Position in GDTC
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,242
New position
Shares Held
7,032
first reported quarter
Ownership
0.059%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 3 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Axiom Investment Management LLC holds $888,066 across 27 Biotechnology names. GDTC ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
507 | $251,842 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
2,000 | $245,160 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
1,520 | $82,900 | |
| 4 | ARGX |
Argenx SE
|
69 | $64,013 | |
| 5 | MRNA |
Moderna, Inc.
|
866 | $60,645 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,000 | $60,360 | |
| 7 | PRQR |
ProQR Therapeutics N.V.
|
31,000 | $57,660 | |
| 8 | IFRX |
InflaRx N.V.
|
10,000 | $22,400 |
All Filings in GDTC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,242 | 7,032 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||